| D009682 |
Magnetic Resonance Spectroscopy |
Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). |
In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR |
|
| D001921 |
Brain |
The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. |
Encephalon |
|
| D005260 |
Female |
|
Females |
|
| D005973 |
Glutamine |
A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. |
D-Glutamine,L-Glutamine,D Glutamine,L Glutamine |
|
| D006801 |
Humans |
Members of the species Homo sapiens. |
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man |
|
| D000293 |
Adolescent |
A person 13 to 18 years of age. |
Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths |
|
| D016896 |
Treatment Outcome |
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. |
Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes |
|
| D018698 |
Glutamic Acid |
A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. |
Aluminum L-Glutamate,Glutamate,Potassium Glutamate,D-Glutamate,Glutamic Acid, (D)-Isomer,L-Glutamate,L-Glutamic Acid,Aluminum L Glutamate,D Glutamate,Glutamate, Potassium,L Glutamate,L Glutamic Acid,L-Glutamate, Aluminum |
|
| D020127 |
Recovery of Function |
A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma. |
Function Recoveries,Function Recovery |
|
| D020165 |
Carbamoyl-Phosphate Synthase I Deficiency Disease |
A urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. The disorder is caused by a reduction in the activity of hepatic mitochondrial CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA). (Menkes, Textbook of Child Neurology, 5th ed, pp50-1) |
CPS 1 Deficiency,Carbamoyl-Phosphate Synthase I Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency),Carbamyl-Phosphate Synthetase I Deficiency Disease,Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency,CPS I Deficiency,Carbamoyl Phosphate Synthase (Ammonia) Deficiency Disease,Carbamoyl Phosphate Synthase 1 Deficiency,Carbamoyl Phosphate Synthetase I Deficiency,Carbamoyl Phosphate Synthetase I Deficiency, Hyperammonemia Due To,Carbamoyl-Phosphate Synthase 1 Deficiency Disease,Carbamoyl-Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency),Carbamoyl-Phosphate Synthetase I Deficiency Disease,Carbamoylphosphate Synthetase 1 Deficiency Disease -,Carbamoylphosphate Synthetase I Deficiency Disease,Carbamyl Phosphate Synthetase (CPS) Deficiency,Carbamyl Phosphate Synthetase Deficiency Disease,Carbamyl-Phosphate Synthetase 1 Deficiency Disease,CPS 1 Deficiencies,CPS I Deficiencies,Carbamoyl Phosphate Synthase 1 Deficiency Disease,Carbamoyl Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency),Carbamoyl Phosphate Synthetase I Deficiency Disease,Carbamoylphosphate Synthetase 1 Deficiency Disease,Carbamyl Phosphate Synthetase 1 Deficiency Disease,Carbamyl Phosphate Synthetase I Deficiency Disease |
|